Sherif Refaat, Hanan E Al-Rashidi, Rania A Abd El Azeem, Walaa E Nouh, Sahar Hamed, Zeinab R Attia
{"title":"功能性 TNF-α-308G > a 单核苷酸多态性(rs1800629):与乳腺癌癌变预测指标的关联。","authors":"Sherif Refaat, Hanan E Al-Rashidi, Rania A Abd El Azeem, Walaa E Nouh, Sahar Hamed, Zeinab R Attia","doi":"10.1007/s10549-024-07536-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Compared with all other cancer types, Breast cancer (BC) among women has now exceeded them all as the primary reason for cancer worldwide. The BC represents 11.7% of all cancer cases and accounts for a predestined 2.3 million new cases. It is the fourth primary reason for cancer-associated deaths in women. With a staggering 200-400% increase in the relative incidence of BC in Egypt, there is an urgent need for new diagnostic or predictive markers.</p><p><strong>Purpose: </strong>The current investigation aims to explore the connection of the functional TNF-α<sup>-308</sup>G > A (rs1800629) single-nucleotide polymorphism (SNP) with different breast cancer predictive indices.</p><p><strong>Methods: </strong>The ARMS-PCR method was used for genotyping TNF-α<sup>-308</sup>G > A SNP. Three groups were recruited for the study: 79 patients with benign breast inflammation (BBI); 163 with breast cancer (BC) and 144 controls (C).</p><p><strong>Results: </strong>The TNF-α<sup>-308</sup>G > A SNP was distributed among different groups in a unique pattern; in the control group 63.9% of cases were in the GG, 34% were in the GA, and 2.1% were in the AA. The BC group had 14% GG, 79% GA, and 7% AA, while the BBI group had 24% GG, 76% GA, and 0% AA. The AA genotype and A allele represented a strong significant correlation with risk factors in the BC group (OR<sub>AA</sub>: 14.67 [95% CI = 3.78-56.91] and OR<sub>A</sub>: 0.27 [95% CI = 0.19-0.39], respectively; P < 0.0001) in contrast to the control group. However, in the BBI group, a strong significant correlation was noted with the GA genotype (OR<sub>GA</sub>: 5.93 [95% CI = 3.18-11.04] P < 0.0001). In the BC group, the AA genotype shows a significant increase in Nottingham Prognostic Index (NPI) in positive ER and PR in contrast to the relevant negative ones (P = 0.02 and 0.002, respectively). However, the GA genotype significantly increased NPI in positive Her2 and metastatic patients (P = 0.03 and 0.01, respectively).</p><p><strong>Conclusion: </strong>This research is the first to correlate TNF-α<sup>-308</sup>G > A (rs1800629) SNP in Egyptian BC patients. The A allele, GA & AA genotypes, and the Overdominant model of the TNF-α<sup>-308</sup>G > A gene variants were recorded as prognostic risk factors for BC carcinogenesis.</p>","PeriodicalId":9133,"journal":{"name":"Breast Cancer Research and Treatment","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The functional TNF-α<sup>-308</sup>G > a single-nucleotide polymorphism (rs1800629): association with the predictive indices of breast cancer carcinogenesis.\",\"authors\":\"Sherif Refaat, Hanan E Al-Rashidi, Rania A Abd El Azeem, Walaa E Nouh, Sahar Hamed, Zeinab R Attia\",\"doi\":\"10.1007/s10549-024-07536-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Compared with all other cancer types, Breast cancer (BC) among women has now exceeded them all as the primary reason for cancer worldwide. The BC represents 11.7% of all cancer cases and accounts for a predestined 2.3 million new cases. It is the fourth primary reason for cancer-associated deaths in women. With a staggering 200-400% increase in the relative incidence of BC in Egypt, there is an urgent need for new diagnostic or predictive markers.</p><p><strong>Purpose: </strong>The current investigation aims to explore the connection of the functional TNF-α<sup>-308</sup>G > A (rs1800629) single-nucleotide polymorphism (SNP) with different breast cancer predictive indices.</p><p><strong>Methods: </strong>The ARMS-PCR method was used for genotyping TNF-α<sup>-308</sup>G > A SNP. Three groups were recruited for the study: 79 patients with benign breast inflammation (BBI); 163 with breast cancer (BC) and 144 controls (C).</p><p><strong>Results: </strong>The TNF-α<sup>-308</sup>G > A SNP was distributed among different groups in a unique pattern; in the control group 63.9% of cases were in the GG, 34% were in the GA, and 2.1% were in the AA. The BC group had 14% GG, 79% GA, and 7% AA, while the BBI group had 24% GG, 76% GA, and 0% AA. The AA genotype and A allele represented a strong significant correlation with risk factors in the BC group (OR<sub>AA</sub>: 14.67 [95% CI = 3.78-56.91] and OR<sub>A</sub>: 0.27 [95% CI = 0.19-0.39], respectively; P < 0.0001) in contrast to the control group. However, in the BBI group, a strong significant correlation was noted with the GA genotype (OR<sub>GA</sub>: 5.93 [95% CI = 3.18-11.04] P < 0.0001). In the BC group, the AA genotype shows a significant increase in Nottingham Prognostic Index (NPI) in positive ER and PR in contrast to the relevant negative ones (P = 0.02 and 0.002, respectively). However, the GA genotype significantly increased NPI in positive Her2 and metastatic patients (P = 0.03 and 0.01, respectively).</p><p><strong>Conclusion: </strong>This research is the first to correlate TNF-α<sup>-308</sup>G > A (rs1800629) SNP in Egyptian BC patients. The A allele, GA & AA genotypes, and the Overdominant model of the TNF-α<sup>-308</sup>G > A gene variants were recorded as prognostic risk factors for BC carcinogenesis.</p>\",\"PeriodicalId\":9133,\"journal\":{\"name\":\"Breast Cancer Research and Treatment\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast Cancer Research and Treatment\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10549-024-07536-y\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10549-024-07536-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:与所有其他癌症类型相比,女性乳腺癌(BC)目前已超过所有癌症类型,成为全球癌症的首要原因。乳腺癌占所有癌症病例的 11.7%,新增病例达 230 万例。它是妇女因癌症死亡的第四大主要原因。在埃及,乳腺癌的相对发病率惊人地增长了 200-400%,因此迫切需要新的诊断或预测标志物。目的:本次调查旨在探索功能性 TNF-α-308G > A (rs1800629) 单核苷酸多态性(SNP)与不同乳腺癌预测指数之间的联系:方法:采用ARMS-PCR方法对TNF-α-308G > A SNP进行基因分型。研究共招募了三组患者:79名良性乳腺炎症(BBI)患者、163名乳腺癌(BC)患者和144名对照组(C):结果:TNF-α-308G > A SNP 在不同组别中的分布具有独特的模式;在对照组中,63.9%的病例为 GG 型,34%为 GA 型,2.1%为 AA 型。BC 组中 GG 占 14%,GA 占 79%,AA 占 7%,而 BBI 组中 GG 占 24%,GA 占 76%,AA 占 0%。在 BC 组中,AA 基因型和 A 等位基因与风险因素有很强的相关性(ORAA:14.67 [95% CI = 3.78-56.91] 和 ORA:0.27 [95% CI = 0.19-0.39] ;P GA:5.93 [95% CI = 3.18-11.04] P 结论:该研究首次将 TNF-α-308G > A (rs1800629) SNP 与埃及 BC 患者相关联。A等位基因、GA和AA基因型以及TNF-α-308G > A基因变异的超显性模型被记录为BC癌变的预后风险因素。
The functional TNF-α-308G > a single-nucleotide polymorphism (rs1800629): association with the predictive indices of breast cancer carcinogenesis.
Background: Compared with all other cancer types, Breast cancer (BC) among women has now exceeded them all as the primary reason for cancer worldwide. The BC represents 11.7% of all cancer cases and accounts for a predestined 2.3 million new cases. It is the fourth primary reason for cancer-associated deaths in women. With a staggering 200-400% increase in the relative incidence of BC in Egypt, there is an urgent need for new diagnostic or predictive markers.
Purpose: The current investigation aims to explore the connection of the functional TNF-α-308G > A (rs1800629) single-nucleotide polymorphism (SNP) with different breast cancer predictive indices.
Methods: The ARMS-PCR method was used for genotyping TNF-α-308G > A SNP. Three groups were recruited for the study: 79 patients with benign breast inflammation (BBI); 163 with breast cancer (BC) and 144 controls (C).
Results: The TNF-α-308G > A SNP was distributed among different groups in a unique pattern; in the control group 63.9% of cases were in the GG, 34% were in the GA, and 2.1% were in the AA. The BC group had 14% GG, 79% GA, and 7% AA, while the BBI group had 24% GG, 76% GA, and 0% AA. The AA genotype and A allele represented a strong significant correlation with risk factors in the BC group (ORAA: 14.67 [95% CI = 3.78-56.91] and ORA: 0.27 [95% CI = 0.19-0.39], respectively; P < 0.0001) in contrast to the control group. However, in the BBI group, a strong significant correlation was noted with the GA genotype (ORGA: 5.93 [95% CI = 3.18-11.04] P < 0.0001). In the BC group, the AA genotype shows a significant increase in Nottingham Prognostic Index (NPI) in positive ER and PR in contrast to the relevant negative ones (P = 0.02 and 0.002, respectively). However, the GA genotype significantly increased NPI in positive Her2 and metastatic patients (P = 0.03 and 0.01, respectively).
Conclusion: This research is the first to correlate TNF-α-308G > A (rs1800629) SNP in Egyptian BC patients. The A allele, GA & AA genotypes, and the Overdominant model of the TNF-α-308G > A gene variants were recorded as prognostic risk factors for BC carcinogenesis.
期刊介绍:
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.